Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Recognized as one of the 50 fastest growing companies in New Jersey
September 28, 2015
By: Tim Wright
Editor-in-Chief, Contract Pharma
ADMA Biologics Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, said the company has been recognized as one of the 50 fastest growing companies in New Jersey by NJBIZ, a New Jersey-focused weekly business news publication. “ADMA Biologics is honored to be recognized as one of the fastest growing companies in New Jersey, and we extend our congratulations to the other honorees,” said Adam Grossman, president and chief executive officer, ADMA Biologics. “We are proud of the rapid evolution of our company, and this distinction is a tremendous honor as we look towards the future. At ADMA Biologics, our mission is to offer treatment options to immune-compromised patients, and we remain committed to fulfilling that mission.” In the past three years, ADMA Biologics has accomplished numerous milestones. These milestones include significant year over year revenue growth, completion of an initial public offering with an uplisting to the Nasdaq, completion of a Phase III clinical study with positive results, and the submission of a Biologics License Application to the U.S. Food and Drug Administration. Additionally, ADMA Biologics has secured intellectual property for its lead product candidate which extends to January 2035 and continues to build its New Jersey based commercialization team in preparation for a potential launch of RI-002 during the second half of 2016. The NJBIZ 50 Fastest Growing Companies awards program celebrates New Jersey’s most dynamic companies who progressively contribute to the success of the state’s economic growth and stability. To qualify, companies had to meet selection criteria that included a revenue size of at least $500,000 within the past two out of three years and growth in revenue over a three year period, dating from fiscal year 2012 to 2014. For more information about the NJBIZ 50 Fastest Growing Companies awards program visit www.njbiz.com/events.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !